These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28963545)

  • 1. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
    Kano M; Muratsubaki T; Van Oudenhove L; Morishita J; Yoshizawa M; Kohno K; Yagihashi M; Tanaka Y; Mugikura S; Dupont P; Ly HG; Takase K; Kanazawa M; Fukudo S
    Sci Rep; 2017 Sep; 7(1):12425. PubMed ID: 28963545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls.
    Tanaka Y; Kanazawa M; Kano M; Tashiro M; Fukudo S
    PLoS One; 2018; 13(7):e0199698. PubMed ID: 29979696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome.
    Tanaka Y; Kanazawa M; Kano M; Morishita J; Hamaguchi T; Van Oudenhove L; Ly HG; Dupont P; Tack J; Yamaguchi T; Yanai K; Tashiro M; Fukudo S
    PLoS One; 2016; 11(7):e0157347. PubMed ID: 27448273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
    Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
    Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome.
    Fukudo S; Nomura T; Hongo M
    Gut; 1998 Jun; 42(6):845-9. PubMed ID: 9691924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of heat-sensitive moxibustion on HPA axis in rats with irritable bowel syndrome].
    Zhang H; Xie F; Gong H; Huang H; Chen S; Kang M; Fu Y
    Zhongguo Zhen Jiu; 2017 Dec; 37(12):1315-21. PubMed ID: 29354998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The gastrointestinal motor function in irritable bowel syndrome (IBS)].
    Sagami Y; Hongo M
    Nihon Rinsho; 2006 Aug; 64(8):1441-5. PubMed ID: 16898609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression.
    Videlock EJ; Shih W; Adeyemo M; Mahurkar-Joshi S; Presson AP; Polytarchou C; Alberto M; Iliopoulos D; Mayer EA; Chang L
    Psychoneuroendocrinology; 2016 Jul; 69():67-76. PubMed ID: 27038676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered colonic function and microbiota profile in a mouse model of chronic depression.
    Park AJ; Collins J; Blennerhassett PA; Ghia JE; Verdu EF; Bercik P; Collins SM
    Neurogastroenterol Motil; 2013 Sep; 25(9):733-e575. PubMed ID: 23773726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroacupuncture in the treatment of IBS in rats: investigation of the mechanisms of CRH
    Gao F; Yuan WH; Wu SB; Wang ZB; Zhu GQ; Zhou MQ
    J Neurophysiol; 2023 Aug; 130(2):380-391. PubMed ID: 37435647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response.
    Park SH; Naliboff BD; Shih W; Presson AP; Videlock EJ; Ju T; Kilpatrick L; Gupta A; Mayer EA; Chang L
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 28718999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.
    Chang L; Sundaresh S; Elliott J; Anton PA; Baldi P; Licudine A; Mayer M; Vuong T; Hirano M; Naliboff BD; Ameen VZ; Mayer EA
    Neurogastroenterol Motil; 2009 Feb; 21(2):149-59. PubMed ID: 18684212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insula Activity to Visceral Stimulation and Endocrine Stress Responses as Associated With Alexithymia in Patients With Irritable Bowel Syndrome.
    Kano M; Muratsubaki T; Yagihashi M; Morishita J; Mugikura S; Dupont P; Takase K; Kanazawa M; Van Oudenhove L; Fukudo S
    Psychosom Med; 2020 Jan; 82(1):29-38. PubMed ID: 31609924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.
    Labus JS; Hubbard CS; Bueller J; Ebrat B; Tillisch K; Chen M; Stains J; Dukes GE; Kelleher DL; Naliboff BD; Fanselow M; Mayer EA
    Gastroenterology; 2013 Dec; 145(6):1253-61.e1-3. PubMed ID: 23954313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered psychobiological responsiveness in women with irritable bowel syndrome.
    Suárez-Hitz KA; Otto B; Bidlingmaier M; Schwizer W; Fried M; Ehlert U
    Psychosom Med; 2012; 74(2):221-31. PubMed ID: 22286854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
    Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
    Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.